Optogenetic manipulation of an ascending arousal system tunes cortical broadband gamma power and reveals functional deficits relevant to schizophrenia.
Optogenetic manipulation of an ascending arousal system tunes cortical broadband gamma power and reveals functional deficits relevant to schizophrenia.
复制标题
上行唤醒系统的光遗传学操纵可调节皮质宽带伽马功率,并揭示与精神分裂症相关的功能缺陷。
DOI:
10.1038/s41380-020-0840-3
复制
发表时间:
2021-07
影响因子:
11
通讯作者:
Brown RE
中科院分区:
文献类型:
--
作者:
McNally JM;Aguilar DD;Katsuki F;Radzik LK;Schiffino FL;Uygun DS;McKenna JT;Strecker RE;Deisseroth K;Spencer KM;Brown RE
Increases in broadband cortical electroencephalogram (EEG) power in the gamma band (30–80 Hz) range have been observed in schizophrenia patients and in mouse models of schizophrenia. They are also seen in humans and animals treated with the psychotomimetic agent ketamine. However, the mechanisms which can result in increased broadband gamma power and the pathophysiological implications for cognition and behavior are poorly understood. Here we report that tonic optogenetic manipulation of an ascending arousal system bi-directionally tunes cortical broadband gamma power, allowing on-demand tests of the effect on cortical processing and behavior. Constant, low wattage optogenetic stimulation of basal forebrain (BF) neurons containing the calcium-binding protein parvalbumin (PV) increased broadband gamma frequency power, increased locomotor activity, and impaired novel object recognition. Concomitantly, task-associated gamma band oscillations induced by trains of auditory stimuli, or exposure to novel objects, were impaired, reminiscent of findings in schizophrenia patients. Conversely, tonic optogenetic inhibition of BF-PV neurons partially rescued the elevated broadband gamma power elicited by subanesthetic doses of ketamine. These results support the idea that increased cortical broadband gamma activity leads to impairments in cognition and behavior and identify BF-PV activity as a modulator of this activity. As such, BF-PV neurons may represent a novel target for pharmacotherapy in disorders such as schizophrenia which involve aberrant increases in cortical broadband gamma activity.
登录
查看更多内容
影响因子:
10.6
作者:
Foss-Feig JH;Adkinson BD;Ji JL;Yang G;Srihari VH;McPartland JC;Krystal JH;Murray JD;Anticevic A
通讯作者:
Anticevic A
影响因子:
16.2
作者:
Bastos AM;Usrey WM;Adams RA;Mangun GR;Fries P;Friston KJ
通讯作者:
Friston KJ
影响因子:
13.9
作者:
Buzsáki G;Wang XJ
通讯作者:
Wang XJ
影响因子:
16.6
作者:
Anaclet C;Pedersen NP;Ferrari LL;Venner A;Bass CE;Arrigoni E;Fuller PM
通讯作者:
Fuller PM
DOI:
10.1093/brain/awy175
发表时间:
2018-08-01
期刊:
Brain : a journal of neurology
影响因子:
--
作者:
Grent-'t-Jong T;Rivolta D;Gross J;Gajwani R;Lawrie SM;Schwannauer M;Heidegger T;Wibral M;Singer W;Sauer A;Scheller B;Uhlhaas PJ
通讯作者:
Uhlhaas PJ